Atherosclerosis · 2026
Ischemic stroke and intracranial large-artery disease risk in familial hypercholesterolemia: A prospective Japanese study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hattori Yorito, Noda Kotaro, Hori Mika, Nakaoku Yuriko, Ogata Soshiro, Murata Hiroaki, Nishimura Kunihiro, Nagai Atsushi, Yamaguchi Shuhei, Harada-Shiba Mariko, Ihara Masafumi
Аннотация
BACKGROUND AND AIMS: The contribution of dyslipidemia to stroke risk is generally considered weaker than that of hypertension and diabetes. However, some previous studies suggest that dyslipidemia is associated with intracranial major artery stenosis (ICAS) and ischemic stroke, particularly in Asians populations, who are more susceptible to ICAS than Caucasians. We hypothesized that dyslipidemia, and specifically familial hypercholesterolemia (FH), may play a different role in the development of stroke in Asian populations. This study aimed to assess the prevalence and incidence of symptomatic ischemic stroke and ICAS in Japanese patients with FH compared to individuals undergoing Brain Dock.
METHODS: This prospective longitudinal study included FH patients who visited a lipid clinic and underwent brain magnetic resonance imaging (MRI) at the National Cerebral and Cardiovascular Center, alongside participants who underwent brain MRI as part of the Brain Dock screening program in Japan.
RESULTS: In total, 3178 participants who underwent Brain Dock and 150 patients with FH were included. FH was an independent risk factor of a higher prevalence of ICAS (≥50%; adjusted odds ratio: 17.82, 95% confidence interval [CI]: 8.74-36.36), and high symptomatic ischemic stroke incidence (adjusted hazard ratio [aHR]: 5.83, 95% CI: 2.03-16.77). The presence of ICAS was significantly associated with symptomatic ischemic stroke in patients with FH (aHR: 7.73, 95% CI: 1.53-39.06).
CONCLUSIONS: FH may confer a high risk for symptomatic ischemic stroke along with intracranial major artery changes in Japanese patients. These findings highlight the importance of considering ethnic and genetic differences in stroke prevention strategies.
METHODS: This prospective longitudinal study included FH patients who visited a lipid clinic and underwent brain magnetic resonance imaging (MRI) at the National Cerebral and Cardiovascular Center, alongside participants who underwent brain MRI as part of the Brain Dock screening program in Japan.
RESULTS: In total, 3178 participants who underwent Brain Dock and 150 patients with FH were included. FH was an independent risk factor of a higher prevalence of ICAS (≥50%; adjusted odds ratio: 17.82, 95% confidence interval [CI]: 8.74-36.36), and high symptomatic ischemic stroke incidence (adjusted hazard ratio [aHR]: 5.83, 95% CI: 2.03-16.77). The presence of ICAS was significantly associated with symptomatic ischemic stroke in patients with FH (aHR: 7.73, 95% CI: 1.53-39.06).
CONCLUSIONS: FH may confer a high risk for symptomatic ischemic stroke along with intracranial major artery changes in Japanese patients. These findings highlight the importance of considering ethnic and genetic differences in stroke prevention strategies.